The novel treatment of this peptide represents a significant advance in the management of the condition. Distinct from existing drugs, tirzepatide targets two pathways – GLP-1 and the GIP hormone – providing https://tirzepatidepeptide781151.digitollblog.com/41948214/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment